Topic: infectious disease
Brii Biosciences is expanding on existing partnerships and inking a new deal with VBI Vaccines that could be worth up to $128.5 million.
The pact tasks Weissmann’s UPenn lab with taking vaccines against up to 10 infectious diseases through to the completion of IND-enabling studies.
Qpex Biopharma launched as a new infectious disease company, simultaneously obtaining $33 million and preclinical assets from The Medicines Company.
The Chan Zuckerberg Biohub has unveiled an open-source platform for charting international infectious disease outbreaks in real time.
Insights into how bacteria hibernate and use metals to evade destruction by antibiotics could be useful in drug development.
MeMed raised $70 million for its immune system diagnostic for distinguishing between bacterial and viral infections, to reduce antibiotic misuse.
Using CRISPR screening, a UT Southwestern team found an interferon-stimulated gene that's key to resisting Zika.
An engineered form of a naturally occurring molecule can penetrate hard-to-kill, Gram-negative bacteria.
China’s Jacobio Pharmaceuticals raised $55 million to advance a cancer drug into the clinic, conduct preclinical work and ramp up its R&D pipelines.